Gliosarcoma
What's New
Last Posted: Mar 15, 2023
- Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors.
Kim Hyunhee, et al. Laboratory investigation; a journal of technical methods and pathology 2023 0 (2) 160-171 - Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma.
Fontanilles Maxime, et al. Acta neuropathologica communications 2020 0 (1) 179 - Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma.
Pierscianek Daniela, et al. Clinical neurology and neurosurgery 2020 0 106348 - Genomic landscape of gliosarcoma: distinguishing features and targetable alterations.
Zaki Mark M, et al. Scientific reports 2021 9 (1) 18009 - Gliosarcoma Is Driven by Alterations in PI3K/Akt, RAS/MAPK Pathways and Characterized by Collagen Gene Expression Signature.
Wojtas Bartosz, et al. Cancers 2019 2 (3) - High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients.
Cho Sung-Yup, et al. Experimental & molecular medicine 2017 4 (4) e317 - An IDH1-mutated primary gliosarcoma: case report.
Hsieh Jason K, et al. Journal of neurosurgery 2016 5 1-5 - Gliosarcoma
From NCATS Genetic and Rare Diseases Information Center
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 18, 2024
- Content source: